摘要
目的探析MP-Ig M检测对确诊小儿支原体肺炎的价值。方法方便选取该院2015年6月—2016年3月收治的400例疑为小儿支原体肺炎患儿,对其临床资料进行回顾性分析,所有患儿均给予MP-Ig M检测,并将诊断结果与C反应蛋白结果进行比较,分析支原体肺炎患儿的患病特点,MP-Ig M检测对诊断支原体肺炎的价值。结果该组400例疑为小儿支原体肺炎的患儿,经过MP-Ig M检测后,其诊断为小儿支原体肺炎者298例,治疗后确诊为小儿支原体肺炎者298例,其符合率为100%(298/298),1~5岁阳性率94.0%,6~10岁阳性率59.15%,11~15岁阳性率36.11%,说明年龄越小,患病率越高;6~8月患病率8.07%,9~11月患病率38.25%,12~次年3月患病率55.03%,说明以冬季患病患儿居多。结论对于支原体肺炎的诊断,采取MP-Ig M检测,准确率比较高,掌握患儿患病特点,早期发现,早期治疗,降低重症支原体肺炎的发生,同时为小儿支原体肺炎的治疗提供可靠依据。
Objective To study the value of MP-IgM in diagnosis of primary atypical pneumonia. Methods 400 cases of children suspected with primary atypical pneumonia admitted and treated in our hospital from June 2015 to March 2016 were convenient selected and tested by the MP-IgM, and the diagnosis results were compared with the C-reactive protein results, and the disease features of children with primary atypical pneumonia and value of MP-IgM in diagnosis of primary atypical pneumonia were analyzed. Results In the 400 cases of children with primary atypical pneumonia, 298 cases were diagnosed with primary atypical pneumonia after the MP-IgM test, and the coincidence rate was 100%（298/298）, the positive rate of children aged between 1 to 5 was 94.0%, the positive rate of children aged between 6 to 10 was 59.15% and the positive rate of children aged between 11 to 15 was 36.11%, which showed that the younger the age, the higher the incidence rate of disease, and the morbidity rate was 8.07% from June to August, 38.25% from September to November and55.03% from December to March next year, and it showed that the morbidity rate of children was the most in Winter. Conclusion The accuracy of MP-IgM test for primary atypical pneumonia is high, and we should master the sick features of children, early discover and treat the disease thus reducing the occurrence of severe mycoplasma pneumonia, and provide reliable basis for the treatment of mycoplasma pneumonia in children.
出处
《中外医疗》
2017年第2期44-46,共3页
China & Foreign Medical Treatment
